Aristada Initio

Active Ingredient(s): Aripiprazole Lauroxil
FDA Approved: * June 29, 2018
Pharm Company: * ALKERMES INC
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Aristada Initio Overview

Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic.[5] It is primarily used in the treatment of schizophrenia and bipolar disorder.[5] Other uses include as an add-on treatment in major depressive disorder, tic disorders and irritability associated with autism.[5] It is taken by mouth or injection into a muscle.[5] A Cochrane review found evidence of effectiveness in treating schizophrenia....

Read more Aristada Initio Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Aristada Initio Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Aripiprazole Lauroxil
  • Injection: 441mg, 662mg, 7.5mg, 882mg, 9.75mg/1.3ml (7.5mg/ml)
  • Solution: 1mg/ml
  • Suspension, Extended Release: 1064mg/3.9ml (272.82mg/ml), 441mg/1.6ml (275.63mg/ml), 662mg/2.4ml (275.83mg/ml), 675mg/2.4ml, 882mg/3.2ml (275.63mg/ml)
  • Tablet: 10mg, 15mg, 20mg, 2mg, 30mg, 5mg
  • Tablet, Orally Disintegrating: 10mg, 15mg, 20mg, 30mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Aristada Initio: (1 result)

Sorted by National Drug Code
  • 65757-500 Aristada Initio 675 mg/2.4ml Intramuscular Injection, Suspension, Extended Release by Alkermes, Inc.

Other drugs which contain Aripiprazole Lauroxil or a similar ingredient: (5 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 5 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA